- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05611944
Irrigation and Suction Trial to Prevent SSI (I&S)
November 10, 2022 updated by: Shazia Saaqib, King Edward Medical University
Laparotomy Wound Care With Irrigation and Negative Pressure Technique in High-risk Cases of Surgical Site Infection(SSI)-A Randomized Controlled Trial
The study will be conducted on women with risk factors for SSI assigned to gynecological surgery with an open abdominal approach.
The participants will be designated to either Irrigation and suction arm by bilateral drain insertion or the control arm by randomization through the parallel assignment.
The participants will be followed for the outcome for four days in the hospital and then at 4 weeks, 8 weeks and 12 weeks postoperatively.
The primary outcome measure will be the SSI rate.
Secondary outcomes will be signs of SSI, post-operative pain, other complications and patient satisfaction.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
This study will be carried out in Lady willingdon Hospital, Lahore.
In this study, we will recruit middle-aged and elderly diabetic women who have been assigned to open abdominal hysterectomy due to different gynaecological reasons.
This cohort is at great risk of surgical site infection and other risk factors of SSI like hypertension, hepatitis and malignancy may coexist in these women.
The study period will span to include three hundred participants as calculated according to sample size.
The women will be divided into either an I&S group or a control group by a simple random number container method.
The women in the I&S group will be inserted with bilateral drains during surgery in subcutaneous tissue after the closure of the rectus sheath and irrigated with saline followed by suction through syringe suction attached to the wound for rest of the day.
The procedure will continue for three days.
On the fourth day, drains are removed and stitches are removed on the fourth postoperative day.
In the control group, the wound will be closed by interrupted stitches without the insertion of subcutaneous drains.
The dressing will be done daily for seven days.
patients with no symptoms and signs of SS will be sent home on the eighth postoperative day.
The patients will be followed for symptoms of SSI, pain, readmission rate, and other complications at 4,8 and 12 weeks.
Study Type
Interventional
Enrollment (Actual)
300
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Punjab
-
Lahore, Punjab, Pakistan, 042
- Lady Willingdon Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
37 years to 76 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Diabetic patients
- age above 40years
- BMI>25kg/m2
- assigned to hysterectomy
- fit for anaesthesia
- patients with other medical disorders like hepatitis and hypertension will also be included in the study.
Exclusion Criteria:
- a BMI of less than 25kg/m2
- a preoperative haemoglobin level of less than 10 g/dl.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: I&S arm
The 150 participants of the experimental arm will be assigned to the I&S group and they will be inserted bilateral Nelton drains of 24 sizes in the subcutaneous space after the closure of the rectus sheath.
Their wound will be irrigated with 500cc Normal saline at running speed followed by suction for a full day.
The procedure will be repeated for three consecutive days.
The drains will be removed on the fourth postoperative day.
|
Irrigation of wound will done by attaching 500cc saline to the drain on one side and let it flow freely from the other drain followed by suction of wound by attaching 60cc suction syringes on both sides creating suction pressure for 100 cc fluid.
|
|
No Intervention: control
The 150 participants of the non-intervention group will be assigned to the control arm, The wound will be closed by interrupted mattress stitches without the insertion of subcutaneous drains.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
SSI rate
Time Frame: first postoperative day to eighth postoperative day
|
number(proportion)of surgical site infections in Intervention and control group
|
first postoperative day to eighth postoperative day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
length of wound disruption
Time Frame: at the time of diagnosis
|
proportion of wound involved
|
at the time of diagnosis
|
|
Depth of wound disruption
Time Frame: at the time of diagnosis
|
involving skin margins=1,subctaneous tissue=2,rectus sheath=3,peritoneum=4, 4 is the worst outcome
|
at the time of diagnosis
|
|
pain score during hospital stay
Time Frame: from first postoperative day to eightth postoperative day
|
composit mean pain score from 0-10, 10 will be maximum adverse outcome
|
from first postoperative day to eightth postoperative day
|
|
pain score after discharge
Time Frame: from discharge to completion of 12 postoperative weeks
|
composite mean pain scorefrom 0-10, 10 will be maximum adverse outcome on week4, week8, week12
|
from discharge to completion of 12 postoperative weeks
|
|
Other complications
Time Frame: from discharge to completion of 12 postoperative weeks
|
complications of wound in I&S group and control group
|
from discharge to completion of 12 postoperative weeks
|
|
patient satisfaction
Time Frame: at12th postoperative weeks completion
|
not satisfied=0, satisfied=1,very satisfied=2,2 is best outcome
|
at12th postoperative weeks completion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Mohammmad Khalid, MBBS,MHM, Pakistan Institute of Cardiology
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Flow Investigators. Fluid lavage of open wounds (FLOW): design and rationale for a large, multicenter collaborative 2 x 3 factorial trial of irrigating pressures and solutions in patients with open fractures. BMC Musculoskelet Disord. 2010 May 6;11:85. doi: 10.1186/1471-2474-11-85.
- Hasan MY, Teo R, Nather A. Negative-pressure wound therapy for management of diabetic foot wounds: a review of the mechanism of action, clinical applications, and recent developments. Diabet Foot Ankle. 2015 Jul 1;6:27618. doi: 10.3402/dfa.v6.27618. eCollection 2015.
- Ivanzov S, Soynov I, Kulyabin Y, Zubritskiy A, Voitov A, Omelchenko A, Arkhipov A, Bogachev-Prokophiev A. Vacuum-assisted closure versus closed irrigation for deep sternal wound infection treatment in infants: a propensity score-matched study. Interact Cardiovasc Thorac Surg. 2019 Nov 1;29(5):776-782. doi: 10.1093/icvts/ivz167.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2017
Primary Completion (Actual)
December 31, 2021
Study Completion (Actual)
March 31, 2022
Study Registration Dates
First Submitted
October 29, 2022
First Submitted That Met QC Criteria
November 3, 2022
First Posted (Actual)
November 10, 2022
Study Record Updates
Last Update Posted (Actual)
November 15, 2022
Last Update Submitted That Met QC Criteria
November 10, 2022
Last Verified
November 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 215/RC/KEMU
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
The IPD will be shared after publication of the study.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabete Mellitus
-
SeraxisNot yet recruitingDiabete Mellitus | Diabete Type 1
-
Medanta, The Medicity, IndiaCompletedDiabete Mellitus | Diabete Type 2 | Hyperglycaemia (Diabetic)India
-
Rio Grande do Sul State Health Department - SES/RSAgnes Nogueira Gossenheimer; Ana Paula Rigo; Roberto Eduardo SchneidersNot yet recruitingTelemedicine | Diabete Mellitus | Diabete Type 2 | TelehealthBrazil
-
Assiut UniversityNot yet recruiting
-
King Abdulaziz UniversityEnrolling by invitation
-
Hospices Civils de LyonCompletedDiabete Type 2 | Diabete Type 1France
-
Washington University School of MedicineNational Heart, Lung, and Blood Institute (NHLBI); University of Abuja Teaching...Not yet recruiting
-
Dong-A ST Co., Ltd.Not yet recruiting
-
Assiut UniversityNot yet recruiting
-
Ariba ShafiqCompleted
Clinical Trials on Irrigation and suction through subcutaneus drains
-
The First People's Hospital of ZunyiCompletedDysphagia | Stroke Associated Pneumonia | Non Severe Ischemic StrokeChina
-
Affiliated Hospital of Nantong UniversityRecruiting
-
Southeast University, ChinaCompleted
-
Case Comprehensive Cancer CenterWithdrawn